ES2182485T3 - Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos. - Google Patents

Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.

Info

Publication number
ES2182485T3
ES2182485T3 ES99904393T ES99904393T ES2182485T3 ES 2182485 T3 ES2182485 T3 ES 2182485T3 ES 99904393 T ES99904393 T ES 99904393T ES 99904393 T ES99904393 T ES 99904393T ES 2182485 T3 ES2182485 T3 ES 2182485T3
Authority
ES
Spain
Prior art keywords
isosazoline
aminofenil
antimicrobial agents
alkyl
derivatives substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99904393T
Other languages
English (en)
Inventor
Michael R Barbachyn
Joel Morris
Donn G Wishka
Richard C Thomas
Gary J Cleek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2182485T3 publication Critical patent/ES2182485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula I **fórmula** o sales farmacéuticamente aceptables del mismo, en la que: R1 es (a) H, (b)alquilo C1-8, que puede estar sustituido con uno o más halo, -OH, alcoxi C1-4 o aciloxi C1-4 (c) cicloalquilo C3-6, (d) alcoxi C1-8, (e) amino o (f) NH(alquilo C1-3), pudiendo estar el alquilo C1- 3 sustituido con uno o más halo; X e Y son independientemente (a) H, (b) F, o (c) CH3; W es (a) O, o (b) S; Q es (a) un resto heterocíclico de 5 miembros que tiene de uno a cuatro átomos de nitrógeno seleccionado entre las estructuras compuestas por i, ii, iii, iv, v, vi, vii, viii y ix; (b) un resto heterocíclico de 9 miembros que tiene de uno a cuatro átomos de nitrógeno seleccionados entre las estructuras compuestas por x, xi, xii, xiv, xv, xvi, xvii, y xviii; (c) un anillo heterocíclico que tiene un átomo de nitrógeno seleccionado entre las estructuras compuestas por ix, xx, xxi, xxii y xxiii;
ES99904393T 1998-02-13 1999-02-03 Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos. Expired - Lifetime ES2182485T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7512698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
ES2182485T3 true ES2182485T3 (es) 2003-03-01

Family

ID=22123719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99904393T Expired - Lifetime ES2182485T3 (es) 1998-02-13 1999-02-03 Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.

Country Status (12)

Country Link
US (1) US6069141A (es)
EP (1) EP1054874B1 (es)
JP (1) JP2002503655A (es)
AT (1) ATE222894T1 (es)
AU (1) AU757197B2 (es)
CA (1) CA2315735A1 (es)
DE (1) DE69902634T2 (es)
DK (1) DK1054874T3 (es)
ES (1) ES2182485T3 (es)
NZ (1) NZ506292A (es)
PT (1) PT1054874E (es)
WO (1) WO1999041244A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025136126A1 (es) 2023-12-21 2025-06-26 Agrovet Market S.A. Composición oral en forma de gel bioadhesivo a base de isoxazolina

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
ATE315033T1 (de) * 1998-08-07 2006-02-15 Chiron Corp Subtituierte isoxazole derivate als estrogen rezeptor modulatore
US6297242B1 (en) * 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
GB9928568D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6861433B2 (en) 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
EP1349853B1 (en) 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
WO2004033449A1 (en) * 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds
ES2421139T3 (es) * 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
GB0403629D0 (en) * 2004-02-19 2004-03-24 Imp College Innovations Ltd Methods
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7767677B2 (en) 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2006124897A2 (en) * 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
CN101252935A (zh) * 2005-08-24 2008-08-27 莱西肯医药有限公司 吡咯并吡啶，吡咯并嘧啶和吡唑并吡啶化合物，包含它们的组合物及它们的使用方法
CN101070308B (zh) * 2007-06-19 2011-05-04 天津药物研究院 异噁唑啉衍生物及其用途
CN101220000B (zh) * 2007-12-28 2010-12-22 天津药物研究院 酰氯和磺酰氯类衍生物及其用途
WO2009102761A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
CN101675931B (zh) * 2008-09-19 2011-09-07 天津药物研究院 酰氯和磺酰氯类衍生物在制备抗肿瘤药物的用途
CN101781294B (zh) * 2010-03-10 2012-02-01 天津药物研究院 一类咪唑的衍生物、其制备方法和用途
EP2602248A1 (en) 2011-12-05 2013-06-12 University Of Leicester Novel pyrrole compounds
MA42145B1 (fr) 2015-05-20 2020-05-29 Amgen Inc Triazoles agonistes du récepteur apj
EP3452466B1 (en) 2016-05-03 2020-08-12 Amgen Inc. Heterocyclic triazole compounds as agonists of the apj receptor
US11046680B1 (en) 2016-11-16 2021-06-29 Amgen Inc. Heteroaryl-substituted triazoles as APJ receptor agonists
US10906890B2 (en) 2016-11-16 2021-02-02 Amgen Inc. Triazole phenyl compounds as agonists of the APJ receptor
EP3541792B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole furan compounds as agonists of the apj receptor
EP3541803B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
WO2018093577A1 (en) 2016-11-16 2018-05-24 Amgen Inc. Cycloalkyl substituted triazole compounds as agonists of the apj receptor
EP3541802B1 (en) 2016-11-16 2025-01-01 Amgen Inc. Alkyl substituted triazole compounds as agonists of the apj receptor
US11142522B2 (en) * 2017-02-03 2021-10-12 The Broad Institute, Inc. Compounds, compositions and methods for cancer treatment
WO2019089335A1 (en) 2017-11-03 2019-05-09 Amgen Inc. Fused triazole agonists of the apj receptor
EP3788037A1 (en) 2018-05-01 2021-03-10 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor
WO2021000297A1 (en) * 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents
CN113372276B (zh) * 2021-05-25 2022-04-22 三峡大学 吲唑类衍生物及其应用
TWI917443B (zh) 2021-09-24 2026-03-11 美商默沙東有限責任公司 作為抗菌劑之化合物及其使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137326C (es) * 1967-08-26
US4283403A (en) * 1976-06-14 1981-08-11 Eli Lilly And Company Substituted isoxazolines for control of plant phytopathogens
IE44819B1 (en) * 1976-06-14 1982-04-07 Lilly Co Eli Isoxazoline derivatives and their use as fungicides
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
JP2818820B2 (ja) * 1993-11-26 1998-10-30 ファイザー・インク． 抗炎症剤としての３−アリール−２−イソオキサゾリン類
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
DE69522234T2 (de) * 1994-10-26 2002-05-16 Pharmacia & Upjohn Co., Kalamazoo Phenyloxazolidinone mit antimikrobieller wirkung
DK0807112T3 (da) * 1995-02-03 2001-12-17 Upjohn Co Antimikrobiel heteroaromatisk ringsubstitueret phenyloxazolidinon
ZA969622B (en) * 1995-12-13 1998-05-15 Upjohn Co Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
JP2000516245A (ja) * 1996-08-21 2000-12-05 ファルマシア・アンド・アップジョン・カンパニー 抗菌剤として有用なイソオキサゾリン誘導体類
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025136126A1 (es) 2023-12-21 2025-06-26 Agrovet Market S.A. Composición oral en forma de gel bioadhesivo a base de isoxazolina

Also Published As

Publication number Publication date
EP1054874B1 (en) 2002-08-28
DK1054874T3 (da) 2002-12-30
US6069141A (en) 2000-05-30
PT1054874E (pt) 2003-01-31
AU757197B2 (en) 2003-02-06
WO1999041244A1 (en) 1999-08-19
AU2479799A (en) 1999-08-30
EP1054874A1 (en) 2000-11-29
DE69902634D1 (de) 2002-10-02
JP2002503655A (ja) 2002-02-05
ATE222894T1 (de) 2002-09-15
CA2315735A1 (en) 1999-08-19
DE69902634T2 (de) 2003-04-24
NZ506292A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
PE20021056A1 (es) Derivados de pirazol
FI931901A0 (fi) Azolfoereningar, deras framstaellning och anvaendning
ATE230402T1 (de) Hemmer der retroviralen protease
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
ECSP045224A (es) Tripéptidos inhibidores de la hepatitis c
ATE112285T1 (de) Adenosin-derivate, die eine aktivität gegen bluthochdruck haben.
PE20040071A1 (es) Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
DK1054874T3 (da) Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
ID21568A (id) Penggunaan baru untuk turunan 1,3-propanadiol
ATE103177T1 (de) Verwendung von alkylphospholipiden als antivirale arzneimittel, sowie neue verbindungen.
ATE164844T1 (de) Azolverbindungen, ihre herstellung und verwendung als antimykotische mittel
EA200000787A1 (ru) Промежуточные соединения для получения ациклических нуклеозидов
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
PT1157998E (pt) Compostos heterociclicos seus intermediarios e inibidores da elastase
ATE144530T1 (de) Glutathionderivat
DK0458387T3 (da) Isochromanderivater
ATE72435T1 (de) Derivate von phenyl-, pyrrolidin-2-ylsubstituierten 5-ring heterocyclen mit antipsychotischer wirkung.
NO904187L (no) Benzanilider.
NO955176L (no) Benzenderivat nyttig for ischemiske sykdommer
CO5180536A1 (es) Inhibidores de proteasas catepsina
UY26416A1 (es) Compuestos
DE69835966D1 (de) Medizinische anwendungen von phenylalkanolen und derivaten davon
DE69329618D1 (de) 3-oxo-1,4-benzothiazin-derivate
ATE120188T1 (de) 15-deoxyprostaglandinderivat.